Shanghai Fosun Pharmaceutical Group Co Ltd (2196)

Currency in HKD
19.81
+1.02(+5.43%)
Closed·
2196 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.7019.95
52 wk Range
12.7829.00
Key Statistics
Bid/Ask
19.81 / 19.81
Prev. Close
18.79
Open
18.77
Day's Range
18.7-19.95
52 wk Range
12.78-29
Volume
5.09M
Average Volume (3m)
2.97M
1-Year Change
31.1921%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2196 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.76
Upside
+50.23%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Employees
40603
Market
Hong Kong

Compare 2196 to Peers and Sector

Metrics to compare
2196
Peers
Sector
Relationship
P/E Ratio
18.4x17.9x−0.4x
PEG Ratio
0.820.430.00
Price/Book
1.3x2.0x2.6x
Price / LTM Sales
1.5x2.3x3.1x
Upside (Analyst Target)
45.3%23.3%57.3%
Fair Value Upside
Unlock21.7%8.0%Unlock

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 29.76
(+50.23% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Hold27.35+38.06%18.62MaintainOct 31, 2025
Citi
Buy35.30+78.19%25.00MaintainSep 18, 2025
Goldman Sachs
Hold18.62-6.01%16.38MaintainAug 28, 2025
HSBC
Hold17.20-13.18%13.00MaintainJun 10, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.27%
Dividend Yield
1.86%
Industry Median 2.60%
Annualized payout
0.35
Paid annually
5-Years Growth
-1.93%
Growth Streak

Earnings

Latest Release
Mar 23, 2026
EPS / Forecast
0.32 / 0.30
Revenue / Forecast
12.27B / 9.92B
EPS Revisions
Last 90 days

2196 Income Statement

FAQ

What Is the Shanghai Fosun Pharmaceutical (2196) Stock Price Today?

The Shanghai Fosun Pharmaceutical stock price today is 19.81 HKD.

What Stock Exchange Does Shanghai Fosun Pharmaceutical Trade On?

Shanghai Fosun Pharmaceutical is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Shanghai Fosun Pharmaceutical?

The stock symbol for Shanghai Fosun Pharmaceutical is "2196."

Does Shanghai Fosun Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Shanghai Fosun Pharmaceutical dividend yield is 1.77%.

What Is the Shanghai Fosun Pharmaceutical Market Cap?

As of today, Shanghai Fosun Pharmaceutical market cap is 78.22B HKD.

What Is Shanghai Fosun Pharmaceutical's Earnings Per Share (TTM)?

The Shanghai Fosun Pharmaceutical EPS (TTM) is 1.27.

When Is the Next Shanghai Fosun Pharmaceutical Earnings Date?

Shanghai Fosun Pharmaceutical will release its next earnings report on Apr 29, 2026.

From a Technical Analysis Perspective, Is 2196 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Shanghai Fosun Pharmaceutical Stock Split?

Shanghai Fosun Pharmaceutical has split 0 times.

How Many Employees Does Shanghai Fosun Pharmaceutical Have?

Shanghai Fosun Pharmaceutical has 40603 employees.

What is the current trading status of Shanghai Fosun Pharmaceutical (2196)?

As of Mar 27, 2026, Shanghai Fosun Pharmaceutical (2196) is trading at a price of 19.81 HKD, with a previous close of 18.79 HKD. The stock has fluctuated within a day range of 18.70 HKD to 19.95 HKD, while its 52-week range spans from 12.78 HKD to 29.00 HKD.

What Is Shanghai Fosun Pharmaceutical (2196) Price Target According to Analysts?

The average 12-month price target for Shanghai Fosun Pharmaceutical is 29.76 HKD, with a high estimate of 35.65148425 HKD and a low estimate of 24.95467936 HKD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +50.23% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.